Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000288425

Medchemexpress LLC CBPD-409, a PROTAC CBP/p300 degrader | 3037549-86-0 | 99.4% | 862.97 g·mol⁻¹ | C46H52F2N10O5 | 10 MG
SDP

Supplier:  Medchemexpress LLC HY15811310MG

Encompass_Preferred

CBPD-409 is an orally active PROTAC degrader that targets the CBP and p300 bromodomain-containing proteins. It shows potent degradation (DC50 0.2-0.4 nM) and low-nanomolar antiproliferative activity in AR+ prostate cancer cell lines, making it suitable for preclinical studies of CBP/p300 biology and degrader pharmacology.

  • Potent degradation activity (DC50 0.2-0.4 nM)
  • Low-nanomolar antiproliferative activity in AR+ prostate cancer cell lines (IC50 1.2-2.0 nM)
  • High supplied purity (>99%)
  • Supplied as a powder suitable for formulation in solvent for assays
  • Recommended storage to preserve stability: powder -20°C long term; in solvent -80°C up to 6 months

Catalog No. 50-002-88425


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.